Jennifer Hall, PhD

Dr. Jennifer Hall is the Chief of Data Science and the co-director of the Institute for Precision Cardiovascular Medicine at the American Heart Association. She leads the Association’s groundbreaking initiatives in cardiovascular medicine by leveraging data analysis, new technologies and strategic alliances to fulfill the promise of precision medicine: that integrating real-world data can enable and accelerate the development of innovative solutions to prevent or mitigate the impact of chronic diseases.

At the intersection of health, technology and science, Dr. Hall leads a highly diversified team of experts in data science, health research, metrics and evaluation, health technology and products. These powerful factors come together to drive new evolutions in science through the Association’s Precision Medicine Platform, a cloud-based technology solution that empowers the global medical research community to accelerate breakthroughs in cardiovascular and brain diseases. Dr. Hall also leads the Research Goes Red initiative, which calls on women throughout the U.S. to contribute to health research. Dr. Hall oversees a diversified research grant portfolio focused on funding impactful and groundbreaking areas of health research. Since 2013, the Institute has invested more than $30 million in 95 grant awardees ranging from collaborative teams of geneticists and engineers to data scientists and imaging experts.

Dr. Hall is an adjunct professor at the University of Minnesota and has served on numerous national and international committees. She is the past Chair of the Functional Genomics and Translational Biology Council of the American Heart Association and was the founding editor-in-chief of the Journal of Cardiovascular Translational Research.

Service and Honors 

• Co-Chair, Genome Canada, Grant Study Section(2017)
• Distinguished Achievement Award, Functional Genomics Council, AHA (2016)
• Vice-President, International SocietyofCardiovascularTranslational Research (2008-15)
• Outstanding Scholarship and Service, Journal of American College of Cardiology (2014)
• Chair,Functional Genomics Council,AHA (2014-16)
• Associate Editor, Journal of American College of Cardiology (2009-16)
• Elite Reviewer, Journal of American College of Cardiology (2013)
• Co-Chair, AHA,Genomics and Observational Epidemiology Study Section (2009-11)
• Chair, Genome Canada,Grant Study Section (2010)
• National Planning Committee, American Heart Association (2011-12)
• NHLBI PPG Grant Study Section (2011-16)
• Chair, Professional Education and Publications,Functional Genomics Council,AHA (2011-12)
• Founding Editor in Chief,Journal of Cardiovascular Translational Research (2013-16)
• Vice-chair,Functional Genomics Council,AHA (2012-13)
• DNA Framingham Advisory Committee (2010-16)
• Chair,AHA Genomics and Observational Epidemiology Study Section (2012-13)

Our interest is to identify genetic variants that are associated with cardiovascular disease and diabetes and define their biological function. We are currently integrating strategies from multiple disciplines to determine how genetic variants alter the course of disease. These strategies incorporate population genetics, biochemistry, cell biology, and transgenic and knockout animals.

Grants (last five years)

Co-PI, NIH, The AnVIL Data Ecosystem (09/19/2018 – 06/30/2023)

Co-Investigator, NIH, The Commons Alliance: A Partnership to Catalyze the Creation of an NIH Data Commons, (9/30/17 - 6/30/18)

PI, Robert Wood Johnson Foundation Award, Launching an innovative patient-powered research portal to advance two-way patient engagement in precision, (12/2016-12/2017)

Co-Investigator, National Science Foundation Award, Empirically Determined Growth Laws for Vascular Smooth Muscle Cell Mechano-Adaptation (8//2016-7/2019)